| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.10B | +27.6% |
| Cost of Revenue | $2.44B | +47.7% |
| R&D Expense | $856.8M | -6.0% |
| SG&A Expense | $1.29B | +40.5% |
| Operating Income | -$1.46B | -34.8% |
| Interest Expense | $19.7M | -61.8% |
| Pre-tax Income | -$1.58B | -58.2% |
| Income Tax | $5.9M | -47.7% |
| Net Income | -$1.58B |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $281.1M | -38.5% |
| Short-term Investments | $1.52B | -15.6% |
| Current Assets | $2.58B | -7.0% |
| Total Assets | $4.56B | -4.6% |
| Current Liabilities | $3.13B | +27.2% |
| Long-term Debt | $839.5M | +18.0% |
| Total Liabilities | $4.17B | +23.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$237.3M | -133.3% |
| Investing Cash Flow | $186.0M | -30.3% |
| Financing Cash Flow | -$87.5M | -20.7% |
| -57.0% |
| EPS (Basic) | -$4.47 | -48.0% |
| EPS (Diluted) | -$4.47 | -48.0% |
| Stockholders' Equity |
| $388.7M |
| -72.1% |